Literature DB >> 25178875

[Epicardial fat: Imaging and implications for diseases of the cardiovascular system].

M Niemann1, H Alkadhi, A Gotschy, S Kozerke, R Manka.   

Abstract

Since the discovery of the obese (ob) gene product leptin, fat has been considered an endocrine organ. Especially epicardial fat has gained increasing attention in recent years. The epicardial fat plays a major role in fat metabolism; however, harmful properties have also been reported. Echocardiography, computed tomography and cardiac magnetic resonance imaging are the non-invasive tools used to measure epicardial fat volume. This review briefly introduces the basic physiological and pathophysiological considerations concerning epicardial fat. The main issue of this review is the presentation of non-invasive measurement techniques of epicardial fat using various imaging modalities and a literature overview of associations between epicardial fat and common cardiovascular diseases.

Entities:  

Mesh:

Year:  2014        PMID: 25178875     DOI: 10.1007/s00059-014-4146-6

Source DB:  PubMed          Journal:  Herz        ISSN: 0340-9937            Impact factor:   1.443


  91 in total

1.  Epicardial fat: an additional measurement for subclinical atherosclerosis and cardiovascular risk stratification?

Authors:  Matthew R Nelson; Farouk Mookadam; Venkata Thota; Usha Emani; Mohsen Al Harthi; Steven J Lester; Stephen Cha; Jan Stepanek; R Todd Hurst
Journal:  J Am Soc Echocardiogr       Date:  2010-12-24       Impact factor: 5.251

Review 2.  Echocardiographic epicardial fat: a review of research and clinical applications.

Authors:  Gianluca Iacobellis; Howard J Willens
Journal:  J Am Soc Echocardiogr       Date:  2009-12       Impact factor: 5.251

3.  Subepicardial adipose tissue and the presence and severity of coronary artery disease.

Authors:  Nithima Chaowalit; Virend K Somers; Patricia A Pellikka; Charanjit S Rihal; Francisco Lopez-Jimenez
Journal:  Atherosclerosis       Date:  2005-09-23       Impact factor: 5.162

4.  Epicardial fat volume correlates with severity of coronary artery disease in nonobese patients.

Authors:  Koji Okada; Satoru Ohshima; Satoshi Isobe; Ken Harada; Akihiro Hirashiki; Hidehito Funahashi; Kosuke Arai; Daisuke Hayashi; Mutsuharu Hayashi; Hideki Ishii; Toyoaki Murohara
Journal:  J Cardiovasc Med (Hagerstown)       Date:  2014-05       Impact factor: 2.160

5.  Water-fat separation with IDEAL gradient-echo imaging.

Authors:  Scott B Reeder; Charles A McKenzie; Angel R Pineda; Huanzhou Yu; Ann Shimakawa; Anja C Brau; Brian A Hargreaves; Garry E Gold; Jean H Brittain
Journal:  J Magn Reson Imaging       Date:  2007-03       Impact factor: 4.813

6.  Impact of increased visceral and cardiac fat on cardiometabolic risk and disease.

Authors:  A M Sironi; R Petz; D De Marchi; E Buzzigoli; D Ciociaro; V Positano; M Lombardi; E Ferrannini; A Gastaldelli
Journal:  Diabet Med       Date:  2012-05       Impact factor: 4.359

7.  Relationship between epicardial fat measured by 64-multidetector computed tomography and coronary artery disease.

Authors:  Kohichiro Iwasaki; Takeshi Matsumoto; Hitoshi Aono; Hiroshi Furukawa; Masanobu Samukawa
Journal:  Clin Cardiol       Date:  2011-02-01       Impact factor: 2.882

8.  Epicardial adipose tissue in patients with heart failure.

Authors:  Christina Doesch; Dariusch Haghi; Stephan Flüchter; Tim Suselbeck; Stefan O Schoenberg; Henrik Michaely; Martin Borggrefe; Theano Papavassiliu
Journal:  J Cardiovasc Magn Reson       Date:  2010-07-12       Impact factor: 5.364

9.  Positional cloning of the mouse obese gene and its human homologue.

Authors:  Y Zhang; R Proenca; M Maffei; M Barone; L Leopold; J M Friedman
Journal:  Nature       Date:  1994-12-01       Impact factor: 49.962

10.  Computer-aided non-contrast CT-based quantification of pericardial and thoracic fat and their associations with coronary calcium and Metabolic Syndrome.

Authors:  Damini Dey; Nathan D Wong; Balaji Tamarappoo; Ryo Nakazato; Heidi Gransar; Victor Y Cheng; Amit Ramesh; Ioannis Kakadiaris; Guido Germano; Piotr J Slomka; Daniel S Berman
Journal:  Atherosclerosis       Date:  2009-08-21       Impact factor: 5.162

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.